Treating periprosthetic joint infections as biofilms: Key diagnosis and management strategies

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 3, 2015, Pages 192-200

  Tzeng, Alice ^a   Tzeng, Tony H ^b   Vasdev, Sonia ^b   Korth, Kyle ^c   Healey, Travis ^b   Parvizi, Javad ^d   Saleh, Khaled J ^b  

^a Massachusetts Institute of Technology   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Bacterial 16S rRNA; Bacteriophage; Culture negative; Implant associated infection; Quantitative PCR; Quorum sensing quenching

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; COLISTIN; DNA 26S; MEROPENEM; RIFAMPICIN; RNA 16S; BACTERIAL DNA; RIBOSOME DNA;

AEROBIC CELL CULTURE; ANAEROBIC CELL CULTURE; ANTIBIOTIC THERAPY; ARTHROCENTESIS; ARTHROPLASTY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIOPHAGE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BIOFILM; CANDIDA ALBICANS; COST CONTROL; DEBRIDEMENT; DEVICE REMOVAL; DNA MICROARRAY; ELECTROSTIMULATION THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGAL EXAMINATION; GENE AMPLIFICATION; HUMAN; JOINT PROSTHESIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL COLONIZATION; MOLECULAR DIAGNOSIS; NONHUMAN; PERIPROSTHETIC JOINT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PYROSEQUENCING; QUORUM SENSING; SCANNING ELECTRON MICROSCOPY; ULTRASOUND THERAPY; ARTHRITIS; BACTERIAL INFECTIONS; BACTERIUM; BIOLOGICAL THERAPY; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; PROCEDURES; PROSTHESIS-RELATED INFECTIONS;

ARTHRITIS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; BIOLOGICAL THERAPY; DNA, BACTERIAL; DNA, RIBOSOMAL; ELECTRIC STIMULATION THERAPY; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PROSTHESIS-RELATED INFECTIONS; RNA, RIBOSOMAL, 16S; ULTRASONIC THERAPY;

EID: 84925217478     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.08.018     Document Type: Article

References (114)

1. Achermann Y., Vogt M., Leunig M., Wust J., Trampuz A. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 2010, 48:1208-1214.
2. Ahn J., Yang L., Paster B.J., Ganly I., Morris L., Pei Z., et al. Oral microbiome profiles: 16S rRNA pyrosequencing and microarray assay comparison. PLoS One 2011, 6:e22788.
3. Arciola C.R., Baldassarri L., Campoccia D., Creti R., Pirini V., Huebner J., et al. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials 2008, 29:580-586.
4. Azeredo J., Sutherland I. The uses of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 2008, 9:261-266.
5. Azzam K., Parvizi J., Jungkind D., Hanssen A., Fehring T., Springer B., et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg 2009, 91:142-149.
6. Bader O., Weig M., Taverne-Ghadwal L., Lugert R., Gross U., Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011, 17:1359-1365.
7. Berbari E.F., Marculescu C., Sia I., Lahr B.D., Hanssen A.D., Steckelberg J.M., et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007, 45:1113-1119.
8. Bille E., Dauphin B., Leto J., Bougnoux M.E., Beretti J.L., Lotz A., et al. MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect 2012, 18:1117-1125.
9. Bjarnsholt T., Ciofu O., Molin S., Givskov M., Hoiby N. Applying insights from biofilm biology to drug development-can a new approach be developed?. Nat Rev Drug Discov 2013, 12:791-808.
10. Bjerkan G., Witsø E., Nor A., Viset T., Løseth K., Lydersen S., et al. A comprehensive microbiological evaluation of fifty-four patients undergoing revision surgery due to prosthetic joint loosening. J Med Microbiol 2012, 61:572-581.
11. Bozic K.J., Ries M.D. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005, 87:1746-1751.
12. Bravo L.T.C., Tuohy M.J., Ang C., Destura R.V., Mendoza M., Procop G.W., et al. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J Clin Microbiol 2009, 47:3985-3990.
13. Bu R., Sathiapalan R.K., Ibrahim M.M., Al-Mohsen I., Almodavar E., Gutierrez M.I., et al. Monochrome LightCycler PCR assay for detection and quantification of five common species of Candida and Aspergillus. J Med Microbiol 2005, 54:243-248.
14. Bugli F., Sterbini F.P., Cacaci M., Martini C., Lancellotti S., Stigliano E., et al. Increased production of gliotoxin is related to the formation of biofilm by Aspergillus fumigatus: an immunological approach. Pathog Dis 2014, 70:379-389.
15. Carmen J.C., Roeder B.L., Nelson J.L., Ogilvie R.L., Robison R.A., Schaalje G.B., et al. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 2005, 33:78-82.
16. Carson L., Gorman S.P., Gilmore B.F. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 2010, 59:447-455.
17. Cazanave C., Greenwood-Quaintance K.E., Hanssen A.D., Karau M.J., Schmidt S.M., Gomez Urena E.O., et al. Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol 2013, 51:2280-2287.
18. Chandra J., Patel J.D., Li J., Zhou G., Mukherjee P.K., McCormick T.S., et al. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 2005, 71:8795-8801.
19. Cobrado L., Azevedo M., Silva-Dias A., Ramos J.P., Pina-Vaz C., Rodrigues A. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors?. J Antimicrob Chemother 2012,dks007.
20. Costerton J.W., Ellis B., Lam K., Johnson F., Khoury A.E. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 1994, 38:2803-2809.
21. Costerton J.W., Post J.C., Ehrlich G.D., Hu F.Z., Kreft R., Nistico L., et al. New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol 2011, 61:133-140.
22. Del Pozo J.L., Rouse M.S., Euba G., Kang C., Mandrekar J., Steckelberg J., et al. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother 2009, 53:4064-4068.
23. del Pozo J.L., Rouse M.S., Mandrekar J.N., Sampedro M.F., Steckelberg J.M., Patel R. Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009, 53:35-40.
24. Della Valle C., Parvizi J., Bauer T.W., Dicesare P.E., Evans R.P., Segreti J., et al. Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg 2010, 18:760-770.
25. DeSantis T.Z., Brodie E.L., Moberg J.P., Zubieta I.X., Piceno Y.M., Andersen G.L. High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol 2007, 53:371-383.
26. Donlan R.M. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009, 17:66-72.
27. Dubouix-Bourandy A., de Ladoucette A., Pietri V., Mehdi N., Benzaquen D., Guinand R., et al. Direct detection of Staphylococcus osteoarticular infections by use of Xpert MRSA/SA SSTI real-time PCR. J Clin Microbiol 2011, 49:4225-4230.
28. Ecker D.J., Sampath R., Massire C., Blyn L.B., Hall T.A., Eshoo M.W., et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008, 6:553-558.
29. Ehrlich G.D., Costerton J.W., Altman D., Altman G., Palmer M., Post C., et al. Towards a new paradigm in the diagnosis and treatment of orthopedic infections. Culture negative orthopedic biofilm infections 2012, Vol. 7:129-139. Springer, Berlin Heidelberg. G.D. Ehrlich, P.J. DeMeo, J.W. Costerton, H. Winkler (Eds.).
30. Estrela A.B., Heck M.G., Abraham W.R. Novel approaches to control biofilm infections. Curr Med Chem 2009, 16:1512-1530.
31. Feldman M., Al-Quntar A., Polacheck I., Friedman M., Steinberg D. Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans. PLoS One 2014, 9:e93225.
32. Fenton M., Keary R., McAuliffe O., Ross R., O'Mahony J., Coffey A. Bacteriophage-derived peptidase CHAP(K) eliminates and prevents staphylococcal biofilms. Int J Microbiol 2013, 2013:625341.
33. Furustrand Tafin U., Corvec S., Betrisey B., Zimmerli W., Trampuz A. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012, 56:1885-1891.
34. Gadsby N.J., Onen A., Phillips S.A., Tysall L., Breusch S.J., Simpson H., et al. Evaluation of real-time 16S rDNA PCR and pyrosequencing for routine identification of bacteria in joint fluid and tissue specimens. Open J Med Microbiol 2011, 1:1-6.
35. Gescher D.M., Kovacevic D., Schmiedel D., Siemoneit S., Mallmann C., Halle E., et al. Fluorescence in situ hybridisation (FISH) accelerates identification of Gram-positive cocci in positive blood cultures. Int J Antimicrob Agents 2008, 32(Suppl. 1):S51-S59.
36. Gomez E., Cazanave C., Cunningham S.A., Greenwood-Quaintance K.E., Steckelberg J.M., Uhl J.R., et al. Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol 2012, 50:3501-3508.
37. Greenwood-Quaintance K.E., Uhl J.R., Hanssen A.D., Sampath R., Mandrekar J.N., Patel R. Diagnosis of prosthetic joint infection (PJI) using polymerase chain reaction-electrospray ionization mass spectrometry (PCR-ESI/MS). J Clin Microbiol 2013.
38. Grif K., Heller I., Prodinger W.M., Lechleitner K., Lass-Flörl C., Orth D. Improvement of detection of bacterial pathogens in normally sterile body sites with a focus on orthopedic samples by use of a commercial 16S rRNA broad-range PCR and sequence analysis. J Clin Microbiol 2012, 50:2250-2254.
39. Gristina A.G., Costerton J.W. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin N Am 1984, 15:517-535.
40. Hall-Stoodley L., Stoodley P., Kathju S., Hoiby N., Moser C., Costerton J.W., et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 2012, 65:127-145.
41. Hamady M., Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 2009, 19:1141-1152.
42. Harris L.G., El-Bouri K., Johnston S., Rees E., Frommelt L., Siemssen N., et al. Rapid identification of staphylococci from prosthetic joint infections using MALDI-TOF mass-spectrometry. Int J Artif Organs 2010, 33:568-574.
43. Hill D., Rose B., Pajkos A., Robinson M., Bye P., Bell S., et al. Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol 2005, 43:5085-5090.
44. Hirakawa H., Tomita H. Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistance. Front Microbiol 2013, 4:114.
45. Human Microbiome Project Consortium A framework for human microbiome research. Nature 2012, 486:215-221.
46. Illingworth K.D., Mihalko W.M., Parvizi J., Sculco T., McArthur B., Bitar Ye, et al. How to minimize infection and thereby maximize patient outcomes in total joint arthroplasty: a multicenter approach: AAOS exhibit selection. J Bone Joint Surg 2013, 95:e50. (1-13).
47. Jakobsen T.H., van Gennip M., Phipps R.K., Shanmugham M.S., Christensen L.D., Alhede M., et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother 2012, 56:2314-2325.
48. Jass J., Lappin-Scott H.M. The efficacy of antibiotics enhanced by electrical currents against Pseudomonas aeruginosa biofilms. J Antimicrob Chemother 1996, 38:987-1000.
49. Jensen E.T., Kharazmi A, Lam K., Costerton J.W., Hoiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990, 58:2383-2385.
50. John A.K., Baldoni D., Haschke M., Rentsch K., Schaerli P., Zimmerli W., et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009, 53:2719-2724.
51. Jordan R.W., Smith N.A., Saithna A., Sprowson A.P., Foguet P. Sensitivities, specificities, and predictive values of microbiological culture techniques for the diagnosis of prosthetic joint infection. BioMed Res Int 2014, 2014:180416. (1-5).
52. Kadurugamuwa J.L., Sin L.V., Yu J., Francis K.P., Kimura R., Purchio T., et al. Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother 2003, 47:3130-3137.
53. Keane P.F., Bonner M.C., Johnston S.R., Zafar A., Gorman S.P. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol 1994, 73:687-691.
54. Kelly D., McAuliffe O., Ross R.P., Coffey A. Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol 2012, 54:286-291.
55. Kempf V.A., Trebesius K., Autenrieth I.B. Fluorescent in situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol 2000, 38:830-838.
56. Khoury A.E., Lam K., Ellis B., Costerton J.W. Prevention and control of bacterial infections associated with medical devices. ASAIO J 1992, 38:M174-M178.
57. Krimmer V., Merkert H., von Eiff C., Frosch M., Eulert J., Lohr J.F., et al. Detection of Staphylococcus aureus and Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in situ hybridization. J Clin Microbiol 1999, 37:2667-2673.
58. Kristiansson E., Fick J., Janzon A., Grabic R., Rutgersson C., Weijdegård B., et al. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 2011, 6:e17038.
59. Kurtz S.M., Lau E., Schmier J., Ong K.L., Zhao K., Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplast 2008, 23:984-991.
60. Larsen L.H., Lange J., Xu Y., Schønheyder H.C. Optimizing culture methods for diagnosis of prosthetic joint infections: a summary of modifications and improvements reported since 1995. J Med Microbiol 2012, 61:309-316.
61. Legout L., Senneville E. Periprosthetic joint infections: clinical and bench research. TheScientificWorldJOURNAL 2013, 2013:549091.
62. Lévy P.Y., Fenollar F. The role of molecular diagnostics in implant-associated bone and joint infection. Clin Microbiol Infect 2012, 18:1168-1175.
63. Lonn-Stensrud J., Landin M.A., Benneche T., Petersen F.C., Scheie A.A. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?. J Antimicrob Chemother 2009, 63:309-316.
64. Lonn-Stensrud J., Naemi A.O., Benneche T., Petersen F.C., Scheie A.A. Thiophenones inhibit Staphylococcus epidermidis biofilm formation at nontoxic concentrations. FEMS Immunol Med Microbiol 2012, 65:326-334.
65. Lu T.K., Koeris M.S. The next generation of bacteriophage therapy. Curr Opin Microbiol 2011, 14:524-531.
66. Lynch A.S., Robertson G.T. Bacterial and fungal biofilm infections. Annu Rev Med 2008, 59:415-428.
67. Marklein G., Josten M., Klanke U., Muller E., Horre R., Maier T., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009, 47:2912-2917.
68. Martinez L.R., Mihu M.R., Tar M., Cordero R.J.B., Han G., Friedman A.J., et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J Infect Dis 2010, 201:1436-1440.
69. Melendez D.P., Uhl J.R., Greenwood-Quaintance K.E., Hanssen A.D., Sampath R., Patel R. Detection of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry applied to synovial fluid. J Clin Microbiol 2014, 52:2202-2205.
70. Molina-Manso D., del Prado G., Ortiz-Pérez A., Manrubia-Cobo M., Gómez-Barrena E., Cordero-Ampuero J., et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents 2013, 41:521-523.
71. Moons P., Faster D., Aertsen A. Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms. Viruses 2013, 5:150-161.
72. Moskowitz S.M., Emerson J.C., McNamara S., Shell R.D., Orenstein D.M., Rosenbluth D., et al. Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection. Pediatr Pulmonol 2011, 46:184-192.
73. Moure R., Muñoz L., Torres M., Santin M., Martín R., Alcaide F. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 2011, 49:1137-1139.
74. Neut D., van Horn J.R., van Kooten T.G., van der Mei H.C., Busscher H.J. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Relat Res 2003, 261-268.
75. Nishimura S., Tsurumoto T., Yonekura A., Adachi K., Shindo H. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 2006, 11:46-50.
76. Nistico L., Gieseke A., Stoodley P., Hall-Stoodley L., Kerschner J.E., Ehrlich G.D. Fluorescence "in situ" hybridization for the detection of biofilm in the middle ear and upper respiratory tract mucosa. Auditory and Vestibular Research 2009,191-213. Springer.
77. Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M., et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013, 56:e1-e25.
78. Pandey R., Berendt A.R., Athanasou N.A. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg 2000, 120:570-574.
79. Pastagia M., Schuch R., Fischetti V.A., Huang D.B. Lysins: the arrival of pathogen-directed anti-infectives. J Med Microbiol 2013, 62:1506-1516.
80. Peel T., Dowsey M., Aboltins C., Daffy J., Stanley P. Culture negative prosthetic joint infection-a description of current treatment and outcomes. Clin Microbial 2013, 2:106-110.
81. Pires D., Sillankorva S., Faustino A., Azeredo J. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol 2011, 162:798-806.
82. Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007, 51:1656-1660.
83. Rahman M., Kim S., Kim S.M., Seol S.Y., Kim J. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 2011, 27:1087-1093.
84. Rak M., Barlic-Maganja D., Kavcic M., Trebse R., Cor A. Comparison of molecular and culture method in diagnosis of prosthetic joint infection. FEMS Microbiol Lett 2013, 343:42-48.
85. Ramage G., Robertson S.N., Williams C. Strength in numbers: antifungal strategies against fungal biofilms. Int J Antimicrob Agents 2014, 43:114-120.
86. Rampini S.K., Bloemberg G.V., Keller P.M., Büchler A.C., Dollenmaier G., Speck R.F., et al. Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. Clin Infect Dis 2011, 53:1245-1251.
87. Rediske A.M., Roeder B.L., Nelson J.L., Robison R.L., Schaalje G.B., Robison R.A., et al. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 2000, 44:771-772.
88. Rodríguez-Pardo D., Pigrau C., Lora-Tamayo J., Soriano A., del Toro M.D., Cobo J., et al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect 2014, 20(11). 10.1111/1469-0691.12649.
89. Saginur R., Stdenis M., Ferris W., Aaron S.D., Chan F., Lee C., et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006, 50:55-61.
90. Savichtcheva O., Okayama N., Ito T., Okabe S. Application of a direct fluorescence-based live/dead staining combined with fluorescence in situ hybridization for assessment of survival rate of Bacteroides spp. in drinking water. Biotechnol Bioeng 2005, 92:356-363.
91. Sedghizadeh P.P., Kumar S.K.S., Gorur A., Schaudinn C., Shuler C.F., Costerton J.W. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 2008, 66:767-775.
92. Seng P., Drancourt M., Gouriet F., La Scola B., Fournier P.-E., Rolain J.M., et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543-551.
93. Stoodley P., Nistico L., Johnson S., Lasko L.-A., Baratz M., Gahlot V., et al. Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty: a case report. J Bone Joint Surg 2008, 90:1751-1758.
94. Stoodley P., Ehrlich G.D., Sedghizadeh P.P., Hall-Stoodley L., Baratz M.E., Altman D.T., et al. Orthopaedic biofilm infections. Curr Orthop Pract 2011, 22:558-563.
95. Tay S.B., Yew W.S. Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens. Int J Mol Sci 2013, 14:16570-16599.
96. Titecat M., Loiez C., Senneville E., Wallet F., Dezeque H., Legout L., et al. Evaluation of rapid mecA gene detection versus standard culture in staphylococcal chronic prosthetic joint infections. Diagn Microbiol Infect Dis 2012, 73:318-321.
97. Tottey W., Denonfoux J., Jaziri F., Parisot N., Missaoui M., Hill D., et al. The human gut chip "HuGChip", an explorative phylogenetic microarray for determining gut microbiome diversity at family level. PLoS One 2013, 8:e62544.
98. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357:654-663.
99. Tunney M.M., Patrick S., Gorman S.P., Nixon J.R., Anderson N., Davis R.I., et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 1998, 80:568-572.
100. Uchida K., Yayama T., Kokubo Y., Miyazaki T., Nakajima H., Negoro K., et al. Direct detection of pathogens in osteoarticular infections by polymerase chain reaction amplification and microarray hybridization. J Orthop Sci 2009, 14:471-483.
101. Vergidis P., Patel R. Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections. Infect Dis Clin N Am 2012, 26:173-186.
102. Wanner S., Gstottner M., Meirer R., Hausdorfer J., Fille M., Stockl B. Low-energy shock waves enhance the susceptibility of staphylococcal biofilms to antimicrobial agents in vitro. J Bone Joint Surg Br 2011, 93:824-827.
103. Wellman N., Fortun S.M., McLeod B.R. Bacterial biofilms and the bioelectric effect. Antimicrob Agents Chemother 1996, 40:2012-2014.
104. Wilson K.H., Wilson W.J., Radosevich J.L., DeSantis T.Z., Viswanathan V.S., Kuczmarski T.A., et al. High-density microarray of small-subunit ribosomal DNA probes. Appl Environ Microbiol 2002, 68:2535-2541.
105. Witney A.A., Marsden G.L., Holden M.T., Stabler R.A., Husain S.E., Vass J.K., et al. Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol 2005, 71:7504-7514.
106. Wong S.S.W., Kao R.Y.T., Yuen K.Y., Wang Y., Yang D., Samaranayake L.P., et al. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One 2014, 9:e85836.
107. Xu Y.J., Rudkjobing V.B., Simonsen O., Pedersen C., Lorenzen J., Schonheyder H.C., et al. Bacterial diversity in suspected prosthetic joint infections: an exploratory study using 16S rRNA gene analysis. FEMS Immunol Med Microbiol 2012, 65:291-304.
108. Yele A.B., Thawal N.D., Sahu P.K., Chopade B.A. Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm. Arch Virol 2012, 157:1441-1450.
109. Yilmaz C., Colak M., Yilmaz B.C., Ersoz G., Kutateladze M., Gozlugol M. Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg 2013, 95:117-125.
110. Yu H., Chen S., Cao P. Synergistic bactericidal effects and mechanisms of low intensity ultrasound and antibiotics against bacteria: a review. Ultrason Sonochem 2012, 19:377-382.
111. Zhang S.X. Enhancing molecular approaches for diagnosis of fungal infections. Future Microbiol 2013, 8:1599-1611.
112. Zhang Y.Q., Cai C., Yang Y.X., Weng L.X., Wang L.H. Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid. J Med Microbiol 2011, 60:1643-1650.
113. Zhu J., Kaufmann G.F. Quo vadis quorum quenching?. Curr Opin Pharmacol 2013, 13:688-698.
114. Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 2012, 65:158-168.